Figure 1.
Survival of patients with mammalian target of rapamycin inhibitor vs no mammalian target of rapamycin inhibitor (survival 21.0 ± 4.1 vs 11.2 ± 2.5 mo, P = 0.04). mTOR: Mammalian target of rapamycin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.